Precision For Medicine

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal neoplasm, connective tissue neoplasm, dermatofibrosarcoma protuberans, digestive system disorder, digestive system neoplasm, epithelial neoplasm, fibrosarcoma, gastric neoplasm, head and neck squamous cell carcinoma, histiocytoma, intestinal disorder, leiomyosarcoma, liposarcoma, lung disorder, lung neoplasm, myomatous neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, solitary fibrous tumor, squamous cell carcinoma, stomach disorder, undifferentiated pleomorphic sarcoma	Recruiting	Phase 1	2026-06-11		NCT06789172

Clinical trials